IN2013CH04757A - - Google Patents

Info

Publication number
IN2013CH04757A
IN2013CH04757A IN4757CH2013A IN2013CH04757A IN 2013CH04757 A IN2013CH04757 A IN 2013CH04757A IN 4757CH2013 A IN4757CH2013 A IN 4757CH2013A IN 2013CH04757 A IN2013CH04757 A IN 2013CH04757A
Authority
IN
India
Prior art keywords
methyl
difluorophenyl
triazol
tetrahydrofuran
formula
Prior art date
Application number
Inventor
Thirumalai Rajan Srinivasan
Sahadeva Reddy Maramreddy
Original Assignee
Msn Lab Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Private Ltd filed Critical Msn Lab Private Ltd
Priority to PCT/IN2014/000673 priority Critical patent/WO2015059716A2/en
Priority to EP14855720.0A priority patent/EP3060559A4/en
Priority to IN4757CH2013 priority patent/IN2013CH04757A/en
Priority to US15/031,536 priority patent/US20160237066A1/en
Publication of IN2013CH04757A publication Critical patent/IN2013CH04757A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/26Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention relates to an improved process for the preparation of ((3S,5R)-5-((lH-l,2,4-triazol-l-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl) methyl-4-methyl benzene sulfonate compound of formula-1 through novel intermediates.
IN4757CH2013 2013-10-22 2014-10-21 IN2013CH04757A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/IN2014/000673 WO2015059716A2 (en) 2013-10-22 2014-10-21 Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonate
EP14855720.0A EP3060559A4 (en) 2013-10-22 2014-10-21 Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonate
IN4757CH2013 IN2013CH04757A (en) 2013-10-22 2014-10-21
US15/031,536 US20160237066A1 (en) 2013-10-22 2014-10-21 Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4757CH2013 IN2013CH04757A (en) 2013-10-22 2014-10-21

Publications (1)

Publication Number Publication Date
IN2013CH04757A true IN2013CH04757A (en) 2015-04-24

Family

ID=52993715

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4757CH2013 IN2013CH04757A (en) 2013-10-22 2014-10-21

Country Status (4)

Country Link
US (1) US20160237066A1 (en)
EP (1) EP3060559A4 (en)
IN (1) IN2013CH04757A (en)
WO (1) WO2015059716A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106317032A (en) * 2015-06-15 2017-01-11 重庆圣华曦药业股份有限公司 Preparation method of high purity posaconazole
WO2017051342A1 (en) 2015-09-23 2017-03-30 Biocon Limited Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posaconazole
CN105440022B (en) * 2015-12-31 2017-11-03 重庆威鹏药业有限公司 The preparation method of posaconazole main ring
CN105606736A (en) * 2016-01-27 2016-05-25 重庆华邦制药有限公司 Method for separation determination of posaconazole intermediate Z1 and related substances of posaconazole intermediate Z1
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
CN106397417A (en) * 2016-08-30 2017-02-15 甘肃皓天化学科技有限公司 Preparation method for preparing posaconazole midbody
WO2019077627A1 (en) * 2017-10-16 2019-04-25 Metrochem Api Pvt Ltd. A process for the manufacture of posaconazole
US20220001295A1 (en) * 2018-11-19 2022-01-06 PREM ANAND MUKUND Honavar An improved process to increase the performance on filtrate extention
CN109187824A (en) * 2018-11-30 2019-01-11 无锡福祈制药有限公司 A kind of HPLC analytical method of posaconazole
CN112898279A (en) * 2019-11-19 2021-06-04 爱之源生物科技有限公司 Refining method of high-purity posaconazole
CN111675702A (en) * 2020-04-23 2020-09-18 陕西博森生物制药股份集团有限公司 Preparation method of posaconazole
CN113666915B (en) * 2021-08-27 2022-08-16 江苏海洋大学 Preparation method of posaconazole intermediate
CN117510380B (en) * 2024-01-08 2024-04-05 寿光诺盟化工有限公司 Preparation method of benzenesulfonate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403937A (en) * 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
WO2009141837A2 (en) * 2008-05-21 2009-11-26 Ind-Swift Laboratories Limited Process for preparing posaconazole and intermediates thereof
CN102906087B (en) * 2010-05-19 2016-03-23 桑多斯股份公司 Prepare the method for chiral triazole ketone
CN108329303A (en) * 2011-06-16 2018-07-27 桑多斯股份公司 The method for preparing chipal compounds
EP2758385B1 (en) * 2011-09-19 2018-03-28 MSN Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof

Also Published As

Publication number Publication date
WO2015059716A3 (en) 2015-07-02
EP3060559A4 (en) 2017-05-24
WO2015059716A2 (en) 2015-04-30
EP3060559A2 (en) 2016-08-31
US20160237066A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
IN2013CH04757A (en)
MY172725A (en) Halogen-substituted pyrazol derivatives as pest-control agents
CU20170057A7 (en) DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL
AU2016214496B2 (en) 2-(HET)Aryl-substituted condensed bicyclic Heterocycle Derivatives as pest control agents
CL2016001677A1 (en) 5-Fluoro-4-imino-3- (alkyl / substituted alkyl) -1- (arylsulfonyl) -3,4-dihydropyrimidin-2 (1h) -one and the processes for its preparation.
PH12015502546A1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
TN2015000420A1 (en) Novel compounds and compositions for inhibition of fasn
EA201690473A1 (en) COMBINED COMPOSITION OF TWO ANTI-VIRUS COMPOUNDS
MX2018012085A (en) Heterocyclic gpr119 agonist compounds.
CL2011003180A1 (en) Compounds derived from thiazolylpiperidine; procedure to control harmful phytopathogenic fungi; fungicidal compositions; use of said compounds to control phytopathogenic fungi; process for preparing said compositions; process for preparing said compounds and intermediates.
AU2014230812A8 (en) Process for making benzoxazepin compounds
EA201590380A1 (en) REPLACED PYRAZOLES USED AS BLOCATORS OF N-TYPE CALCIUM CHANNELS
BR112018010140A2 (en) compounds of formula, composition, use of a compound of formula, method for combating phytopathogenic fungi and seed
MX2019013979A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds.
EP3795578A3 (en) Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
MX2018007219A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds.
BR112018010316A2 (en) compounds of formula, composition, use of a compound of formula, method for combating phytopathogenic fungi and seed
CY1122506T1 (en) CRYSTAL FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY- PYRIDIN-4- YL)-[1,2,4]OXADIAZOL-3- YL]-2- ETHYL- 6-METHYL- PHENOXY}-PROPANE-1,2-DIOL
CY1121116T1 (en) NEW METHOD FOR THE COMPOSITION OF AGOMELATIN
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX2013006813A (en) Lactone compounds and materials made therefrom.
MX2016006807A (en) Imidazole derivatives.
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
IN2013MU01219A (en)